Market Place
Sourcing Support
Medicus` Ph2 SKNJCT-003 Shows Positive Basal Cell Carcinoma Data
06 Mar 2025 //
GLOBENEWSWIRE
Medicus Submits Ph 2 Design To UAE DOH For Non-Invasive BCC Treatment
27 Feb 2025 //
GLOBENEWSWIRE
Medicus Updates Ph2 SKNJCT-003 Study In Nodular BCC Treatment
14 Feb 2025 //
GLOBENEWSWIRE
Medicus Signs Equity Deal, Plans Voluntary TSXV Delisting
11 Feb 2025 //
GLOBENEWSWIRE
Medicus Pharma Receives FDA MUMS Designation for D-MNA Patch
12 Dec 2024 //
GLOBENEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.